ArticlePloS one2026
Structural bioinformatic studies of eight integral transmembrane NADPH oxidases and their AlphaFold 3 predicted QTY analogs with reduced hydrophobicity.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The NADPH oxidase (NOX) family comprises integral membrane-bound enzymes responsible for generating reactive oxygen species (ROS), with critical roles in immune defense, vascular regulation, and cellular signaling. However, their intrinsic hydrophobicity and membrane association created longstanding challenges for extensive research. In this study, we applied the QTY code - a simple protein design strategy that replaces hydrophobic residues leucine (L), isoleucine (I), valine (V), and phenylalanine (F) with hydrophilic yet structurally compatible residues glutamine (Q), threonine (T) and tyrosine (Y) - to generate QTY analogs of NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1, DUOXA1 and CYBA with reduced hydrophobicity. Using AlphaFold 3, we predicted and superposed the structures of native and QTY-engineered analog proteins. Our results show strong structural resemblance between each pair, with root mean square deviation (RMSD) values below 1Å for six out of eight proteins examined. In addition, QTY substitution significantly reduced surface hydrophobicity, indicating improved water-solubility while preserving 3D structural fold integrity. Our findings demonstrate the potential of QTY-designed NOX variants with reduced hydrophobicity as surrogates for use in structural biology, monoclonal antibody discoveries, drug discovery, and other applications where native membrane proteins present experimental limitations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.